Gene Therapy Market Size, Trends & Growth Opportunity By Vector Type (Viral, and Nonviral), By Gene Type (Antigen, Cytokine, Growth Factors, Receptors, and Others), By Application (Oncological Disorder, Cardiovascular Diseases, Neurological Disorders, Rare Diseases, Infectious Diseases, and Others), By Region and Forecast till 2027
Report ID : QR10066 | Industries : Healthcare | Published On :October 2021 | Page Count : 255Global Gene Therapy Market
Gene therapy is a type of experimental technique in which genes are used to treat or prevent diseases. In this therapy genes are inserted into patient’s cells instead of using surgery and drugs. Gene therapy has various approaches such as replacement of muted gene, inactivating or knocking out a muted gene, and introducing new gene into the body to help fight a disease.
Global Gene Therapy Market Drivers
Increase in prevalence of chronic diseases like cancer is expected to boost the global gene therapy market, in this forecast period. Furthermore, rise in technological advancements in genomics and gene-editing tool will have the positive impact on gene therapy market growth. In other hand, rapid and significant progress in the molecular and cellular biology arena is expected to propel the global gene therapy market growth. Moreover, rise in product approval is expected to fuel the global gene therapy market growth.
Know more about this report: request for sample pages
Global Gene Therapy Market Restraints
However, high cost is the major restraining factor which is expected to hamper the global gene therapy market growth. Also, lack of skilled professionals is expected to affect the global gene therapy market growth.
Global Gene Therapy Market Segmentation
Global Gene Therapy Market is segmented into vector type such as Viral Sector, and Nonviral Sector, by gene type such as Antigen, Cytokine, Growth Factors, Receptors, and Others. Further, Global Gene Therapy Market is segmented into application such as Oncological Disorder, Cardiovascular Diseases, Neurological Disorders, Rare Diseases, Infectious Diseases, and Others.
Also, Global Gene Therapy Market is segmented into five regions such as North America, Latin America,Europe, Asia Pacific, and Middle East and Africa.
Global Gene Therapy Market Key Players
Various key players are discussed in this report such as BIGEN, Gilead Sciences Inc., Amgen, Novartis AG, Bluebird Bio, Inc, Orchard Therapeutics Plc, Spark Therapeutics ,Human Stem cell Institutes, JAZZ Pharmaceuticals, Sibiono Genetech Co,ltd, UNIQURE N.V,Mustang Bio, and Poseida Therapeutics Inc.
Global Gene Therapy Market Taxonomy
By Types
- Viral Sector
- Nonviral Sector
By Gene Type
- Antigen
- Cytokine
- Growth Factors
- Receptors
- Others
By Application
- Oncological Disorder
- Cardiovascular Diseases
- Neurological Disorders
- Rare Diseases
- Infectious Diseases
- Others
By Region
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East & Africa
Key Questions Addressed by the Report
- What are the Key Opportunities in Gene Therapy Market?
- What will be the growth rate from 2019 to 2027?
- Which segment/region will have highest growth?
- What are the factors that will impact/drive the Market?
- What is the competitive Landscape in the Industry?
- What is the role of key players in the value chain?
- What are the strategies adopted by key players?
Global Gene Therapy Market TOC
1. Executive Summary
1.1. Market Taxonomy
2. Global Gene Therapy Market Demand (in Value or Size in US$ Mn) Analysis and Forecast
3. Market Background
3.1. Forecast Factor
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Challenges
3.2.3. Trends
4. Global Gene Therapy Market Snapshot
5. Global Gene Therapy Market Analysis, By Types
5.1. Y-o-Y Growth Comparison, By Types
5.2. Global Gene Therapy Market Share Analysis, By Types
5.3. Global Gene Therapy Market Size and Forecast, By Types
5.3.1 Viral Sector
5.3.2 Nonviral Sector
6. Global Gene Therapy Market Analysis, By Gene Type
6.1. Y-o-Y Growth Comparison, By Gene Type
6.2. Global Gene Therapy Market Share Analysis, By Gene Type
6.3. Global Gene Therapy Market Size and Forecast, By Gene Type
6.3.1 Antigen
6.3.2 Cytokine
6.3.3 Growth Factors
6.3.4 Receptors
6.3.5 Others
7. Global Gene Therapy Market Analysis, By Application
7.1. Y-o-Y Growth Comparison, By Application
7.2. Global Gene Therapy Market Share Analysis, By Application
7.3. Global Gene Therapy Market Size and Forecast, By Application
7.3.1 Oncological Disorder
7.3.2 Cardiovascular Diseases
7.3.3 Neurological Disorders
7.3.4 Rare Diseases
7.3.5 Infectious Diseases
7.3.6 Others
8. Global Gene Therapy Market Analysis, By Region
8.1. Y-o-Y Growth Comparison, By Region
8.2. Global Gene Therapy Market Share Analysis, By Region
9. North America Gene Therapy Market Analysis and Forecast (2017-2027)
9.1 Introduction
9.2 North America Gene Therapy Market Analysis, By Types
9.3 North America Gene Therapy Market Analysis, By Gene Type
9.4 North America Gene Therapy Market Analysis, By Application
9.5 North America Gene Therapy Market Analysis, By Country
9.5.1USA
9.5.2 Canada
9.5.3 Mexico
10. Europe Gene Therapy Market Analysis and Forecast (2017-2027)
10.1 Introduction
10.2 Europe Gene Therapy Market Analysis, By Types
10.3 Europe Gene Therapy Market Analysis, By Gene Type
10.4 Europe Gene Therapy Market Analysis, By Application
10.5 Europe Gene Therapy Market Analysis, By Country
10.5 .1Germany
10.5 .2 France
10.5 .3 UK
10.5 .4 Rest of Europe
11. Asia Pacific Gene Therapy Market Analysis and Forecast (2017-2027)
11.1 Introduction
11.2 Asia Pacific Gene Therapy Market Analysis, By Types
11.3Asia Pacific Gene Therapy Market Analysis, By Gene Type
11.3Asia Pacific Gene Therapy Market Analysis, By Application
11.4 Asia Pacific Gene Therapy Market Analysis, By Country
11.4.1China
11.4.2 India
11.4.3 Japan
11.4.4 Rest of Asia Pacific
12. Latin America Gene Therapy Market Analysis and Forecast (2017-2027)
12.1 Introduction
12.2 Latin America Gene Therapy Market Analysis, By Types
12.3Latin America Gene Therapy Market Analysis, By Gene Type
12.4Latin America Gene Therapy Market Analysis, By Application
13. Middle East & Africa Gene Therapy Market Analysis and Forecast (2017-2027)
13.1 Introduction
13.2 Middle East & Africa Gene Therapy Market Analysis, By Types
13.3Middle East & Africa Gene Therapy Market Analysis, By Gene Type
13.4Middle East & Africa Gene Therapy Market Analysis, By Application
14. Competition Analysis
14.1 Competition Dashboard
14.2Market Share Analysis of Top Vendors
14.3 Key Development Strategies
15. Company Profiles
15.1 BIGEN
15.1.1 Overview
15.1.2 Offerings
15.1.3 Key Financial
15.1.4 Business Segment & Geographic Overview
15.1.5 Key Market Developments
15.1.6 Key Strategies
15.2 Gilead Sciences Inc
15.3 Amgen
15.4 Novartis AG
15.5 Bluebird Bio Inc
15.6 Spark Therapeutics
15.7 Human Stem cell Institutes
15.8 JAZZ Pharmaceuticals
15.9 Sibiono Genetech Co,ltd
15.10 UNIQURE N.V
15.11 Mustang Bio
15.12 Poseida Therapeutics Inc